Startseite Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?

  • Eline Verhoye , Michel R. Langlois und on behalf of the Asklepios Investigators
Veröffentlicht/Copyright: 22. Dezember 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Low-density lipoproteins (LDLs) are susceptible to structural modifications by oxidation, particularly the small dense LDL particles. The formation of lipid peroxidation derivates, such as thiobarbituric reactive substances, conjugated dienes, lipid hydroperoxides, and aldehydes, is associated with changes in apolipoprotein conformation and affects the functional properties of LDLs. Oxidized LDL (oxLDL) formation in the subendothelial space of the arterial wall is a key initiating step in atherosclerosis because it contributes to foam cell generation, endothelial dysfunction, and inflammatory processes. In the last decade, immunoassays were developed using monoclonal antibodies against oxidation-dependent epitopes of LDL which made it possible to directly measure oxLDL in the circulation. Increased circulating oxLDL concentrations have been related to cardiovascular disease in some studies, although not always independently after adjustment of classical lipid markers. The Asklepios Study, investigating 2524 healthy middle-aged subjects, showed that circulating oxLDL is affected by many biological and lifestyle factors, as well as (generalized) subclinical atherosclerosis.

Clin Chem Lab Med 2009;47:128–37.


Corresponding author: Michel R. Langlois, MD, PhD, Department of Clinical Chemistry, AZ St-Jan Hospital, Ruddershove 10, 8000, Bruges, Belgium Phone: +32-50-452729, Fax: +32-50-452619,

Received: 2008-6-20
Accepted: 2008-10-17
Published Online: 2008-12-22
Published in Print: 2009-02-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
  3. Reviews
  4. Vitamin D: current status and perspectives
  5. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
  6. New European guidelines for cardiovascular disease prevention in clinical practice
  7. Review
  8. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
  9. Genetics and Molecular Diagnostics
  10. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
  11. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
  12. General Clinical Chemistry and Laboratory Medicine
  13. Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
  14. Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
  15. Methodology for monitoring cytomegalovirus infection after renal transplantation
  16. High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
  17. Reference Values and Biological Variations
  18. Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
  19. Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
  20. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
  21. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
  22. Validation and Outcome Studies
  23. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
  24. Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
  25. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
  26. Letters to the Editor
  27. Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
  28. Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
  29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.037/html?lang=de
Button zum nach oben scrollen